Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Arbovirusinfecties in Zuidoost-Europa: Resultaten van MERMAIDS-ARBO
dec 2025 | Virale infecties